US Corporate Board Director Changes SEC Filings — April 21, 2026

21-04-2026

Delek US Holdings, Inc. announced the appointment of Amber Russell as Executive Vice President, Refining, effective April 20, 2026, succeeding Joseph Israel, who is departing after contributions to operational excellence. Ms. Russell brings nearly three decades of experience from ExxonMobil and bp, including senior roles in refining, terminals, and pipelines. Avigal Soreq, President and CEO, highlighted her expertise as key to strengthening Delek's refining platform.

• ·Ms. Russell will be based at Delek’s Brentwood, Tennessee office and report directly to Avigal Soreq.
• ·Announcement dated April 20, 2026; SEC filing April 21, 2026.

21-04-2026

CrowdStrike's Board approved a performance- and service-based equity award of 100,000 target PSUs to President Michael Sentonas under the 2019 Equity Incentive Plan, tied to the company's TSR relative to S&P 500 companies over a three-year period from December 22, 2025, to December 22, 2028, with potential payout from 0 to 200,000 shares based on percentile rankings (50% at 25th percentile threshold, 200% at 90th+). The award recognizes Sentonas's role in driving revenue growth from $3.06B in FY2024 to $4.81B in FY2026 and ARR from $3.44B to $5.25B, alongside a 300% stock return ranking in the 95th percentile of S&P 500 over three years. It aligns incentives with the ambition to reach $20B in ending ARR amid expansions in high-growth markets and strategic acquisitions.

• ·PSU payout levels: 200% at 90th+ percentile TSR, 150% at 75th, 100% at 55th, 50% at 25th, 0% below 25th
• ·Earned PSUs subject to additional one-year service vesting (25% quarterly on Mar 20, Jun 20, Sep 20, Dec 20, 2029)
• ·Performance period: December 22, 2025 to December 22, 2028
• ·Award approved April 16, 2026

21-04-2026

On April 20, 2026, Eduardo Martins, M.D., D.Phil., retired as Chief Medical Officer of Sagimet Biosciences Inc., effective immediately, and will continue as an external scientific advisor. The company appointed Andreas Grauer, M.D., as the new Chief Medical Officer, effective the same date. Dr. Grauer previously served as CMO at Omeros Corporation (October 2023 to April 2026), Federation Bio (October 2021 to July 2023), and Corcept Therapeutics (March 2019 to August 2021), with prior roles at Amgen and Procter & Gamble Pharmaceuticals.

• ·Dr. Grauer held Vice President Global Development role at Amgen from December 2008 to December 2018.
• ·Dr. Grauer is an Associate Professor of Medicine at the University of Heidelberg Medical School.
• ·Series A Common Stock has $0.0001 par value per share and trades as SGMT on Nasdaq Global Market.

21-04-2026

The Simply Good Foods Company announced on April 20, 2026, that Ms. Amy Held, Senior Vice President and Chief Human Resources Officer and a named executive officer, will depart by June 1, 2026, as part of several corporate realignment initiatives. In connection with her departure, Ms. Held will receive benefits under the Company's Third Amended and Restated Executive Severance Plan, and the Compensation Committee accelerated the vesting of her 6,881 time-based Restricted Stock Units to June 1, 2026.

• ·Date of earliest event reported: April 17, 2026
• ·Form 8-K filing date: April 21, 2026

21-04-2026

Bassett Furniture Industries, Inc. (BSET) announced on April 21, 2026, that Bruce Cohenour, SVP-Chief Sales Officer, will retire effective May 31, 2026. No successor was named in the filing. The announcement was made via Form 8-K under Item 5.02.

• ·The Form 8-K was signed by J. Michael Daniel on April 21, 2026.

21-04-2026

ENIGMA-BULWARK, LTD reported that Board Member Mr. Phil Woolas ceased to serve effective March 16, 2026, due to his death, expressing great sadness over the loss of his guidance and contributions. The company noted his extensive background in UK politics, government, and security-related roles. No family relationships exist between Mr. Woolas and other officers or directors.

• ·Phil Woolas previously oversaw UK Border Agency with 120,000 staff and was responsible for portfolios including Local Government funding (circa £130 billion), Immigration Policy, and Civil Contingency Planning.
• ·The filing was signed by Calli Bucci, Chief Financial Officer, on April 20, 2026.

21-04-2026

On April 21, 2026, Virgin Galactic Holdings, Inc. and Galactic Co., LLC amended employment agreements with CFO and Treasurer Douglas Ahrens and Chief People Officer and Executive Vice President, Astronaut Operations Aparna Chitale. The amendments entitle executives to any earned but unpaid prior-year annual bonus upon qualifying termination and, upon qualifying termination within 24 months post-change in control, increase Mr. Ahrens' cash severance multiplier from 1.0 to 1.5 while extending Company-subsidized healthcare coverage for both from 12 to 18 months. No financial performance metrics or other impacts are disclosed.

• ·Qualifying termination defined as Company termination without 'cause' or executive resignation for 'good reason'.
• ·Amendments filed as Exhibits 10.1 (Ahrens) and 10.2 (Chitale).

21-04-2026

Voyager Therapeutics, Inc. announced that Nathan Jorgensen, Ph.D., resigned as Chief Financial Officer effective May 8, 2026, to pursue a new opportunity, with no disagreements with the company. In connection, the board appointed Robin Swartz, current Chief Operating Officer and Chief Business Officer, as principal financial officer and treasurer, and Amy Quinlan, Vice President of Finance, as principal accounting officer, both effective May 8, 2026.

• ·Resignation notified on April 15, 2026; board appointments on April 20, 2026.
• ·Robin Swartz, age 55; previously at Sanofi Genzyme in senior roles.
• ·Amy Quinlan, age 51; no family relationships or disclosable transactions under Item 404(a) for either appointee.

21-04-2026

On April 18, 2026, Randolph C. Read, a director of SandRidge Energy, Inc., notified the company that he will not stand for re-election to the Board of Directors at the 2026 Annual Meeting of Stockholders and will continue serving until the expiration of his current term. Mr. Read's decision was not due to any disagreement with the company's operations, policies, or practices. No other changes to the board or officer positions were reported.

• ·SandRidge Energy, Inc. trades on the New York Stock Exchange under ticker SD (Common Stock, $0.001 par value).

21-04-2026

Spyros Papapetropoulos resigned from Lipocine Inc.'s Board of Directors effective April 16, 2026, where he had served as Chairman, Lead Independent Director, and compensation committee member since 2022, due to competing professional commitments and differing views on the company's strategic direction. The Board appointed R. Dana Ono as the new Chairman and Lead Independent Director on April 20, 2026. No financial or operational impacts from the changes were disclosed.

21-04-2026

On April 16, 2026, Andreas Roellgen ceased serving as Executive Vice President and President of the Engineered Bearings business segment at The Timken Company, effective close of business that day. Timothy A. Graham has assumed interim leadership of the segment, with an external search launched for a permanent successor. The filing notes Mr. Roellgen's European domicile may require local legal processes, potentially leading to an amended 8-K.

• ·Filing submitted on April 21, 2026
• ·Company headquartered at 4500 Mt. Pleasant St. NW, North Canton, OH 44720

21-04-2026

Eric R. Ray, Senior Executive Vice President and Chief Digital Officer of Radian Group Inc., provided notice on April 20, 2026, of his decision to retire from the company effective July 1, 2026. His retirement is not due to any disagreement with the company's operations, policies, or practices. The announcement was filed on April 21, 2026.

• ·Company address: 550 East Swedesford Road, Suite 350, Wayne, Pennsylvania, 19087
• ·Common Stock trading symbol: RDN on New York Stock Exchange

21-04-2026

CAVA Group, Inc. announced that Board member Karen Kochevar will retire upon the expiration of her current term and will not stand for re-election at the 2026 Annual Meeting, concluding her 10 years of service including the company's transition from private to public. The decision is part of the Board's ongoing succession planning process. CEO Brett Schulman thanked Ms. Kochevar for her significant contributions during a period of substantial growth and development.

• ·Filing items: 5.02 (Departure of Directors or Certain Officers), 9.01 (Financial Statements and Exhibits)
• ·Annual Meeting reference: 2026
• ·Media Contact: cava@media.com

21-04-2026

Firefly Aerospace Inc. entered into confirmatory employment letter agreements on April 16, 2026, with executives Jason Kim ($500,000 base salary, 100% bonus target), Darren Ma ($420,000 base salary, 60% bonus target), and Ramon Sanchez ($425,000 base salary, 50% bonus target), superseding prior agreements and including eligibility for company benefit plans and restrictive covenants. On April 15, 2026, the Board approved clarifying amendments to the Executive Severance Plan, and the executives entered participation agreements to become eligible for its benefits. The agreements are filed as Exhibits 10.1 through 10.4.

• ·Filing date: April 21, 2026; Earliest event date: April 15, 2026
• ·Common stock trading symbol: FLY; Par value: $0.0001 per share
• ·Registrant is an emerging growth company

21-04-2026

Dr. Jeffrey Sherman, a director of Xeris Biopharma Holdings, Inc. since 2021 and member of the Compensation Committee and Nominating and Corporate Governance Committee, provided notice on April 20, 2026, of his retirement from the Board and decision not to stand for reelection at the 2026 Annual Meeting. The Board approved a reduction in its size from eight to seven directors effective upon expiration of Dr. Sherman's term. His departure was not due to any disagreement with the Company on operations, policies, or practices.

• ·Dr. Sherman has served on the Compensation Committee and Nominating and Corporate Governance Committee.
• ·The 8-K was filed on April 21, 2026.

21-04-2026

Envoy Medical, Inc. appointed Charles S. McKhann as a Class I director effective April 15, 2026, increasing the Board size from six to seven members; he was also appointed to the Compensation Committee. Mr. McKhann brings extensive medical device experience, including as CEO of Silk Road Medical and Apollo Endosurgery (both acquired by Boston Scientific), and current roles at Exagen, Inc. and Distalmotion SA. He received stock options to purchase 100,000 shares of Class A Common Stock at $0.72 per share, vesting over 36 months, and qualifies as an independent director with no related party transactions.

• ·Stock options vest in 36 equally monthly installments.
• ·Mr. McKhann's initial term expires at the 2027 annual meeting of stockholders.
• ·Mr. McKhann holds a B.A. in Political Science and an M.B.A. from Stanford University.
• ·Standard indemnification agreement executed; no Item 404(a) related transactions.

21-04-2026

Abacus Global Management, Inc. (NYSE: ABX) announced key leadership appointments effective April 17, 2026, including Alexei Solomon as Chief Accounting Officer and Treasurer, and Elena Plesco as Chief Investment Officer, both internal promotions reflecting organizational growth. Samantha Butcher will continue as President of Abacus Life Solutions, and Bill McCauley as Chief Financial Officer and Chief Operating Officer. CEO Jay Jackson praised the team's expertise and commitment.

• ·Alexei Solomon has over 20 years of accounting and finance experience, previously Director of SEC Reporting & Technical Accounting at Abacus.
• ·Elena Plesco has over 15 years of finance and investing experience, previously Chief Capital Officer at Abacus and Co-Head of Specialty Finance at KKR.
• ·Samantha Butcher has been with Abacus for over 20 years.
• ·Investor Relations contacts: Robert F. Phillips (rob@abacusgm.com, (321) 290-1198); David Jackson (david@abacusgm.com, (321) 299-0716).

21-04-2026

Federal Agricultural Mortgage Corporation (Farmer Mac) appointed Mandy M. Talan, its Managing Director – Corporate Controller since June 2025, as principal accounting officer effective April 21, 2026. Ms. Talan, age 45 and a Certified Public Accountant, previously held senior roles at Fannie Mae and KPMG. No agreements, family relationships, or disclosable transactions under Item 404(a) of Regulation S-K exist.

• ·Ms. Talan served as Senior Director of Finance and Regulatory Reporting at Fannie Mae from September 2022 to May 2025.
• ·Ms. Talan was Director of Accounting Policy at Fannie Mae from June 2013 to September 2022.
• ·Ms. Talan was Audit Senior Manager at KPMG from July 2010 to June 2013.

21-04-2026

On April 15, 2026, PPG Industries granted performance-based Market Stock Unit (MSU) awards with a target value of $1,500,000 each to executives K. Henrik Bergstrom and Kevin Braun to align with shareholder interests over three years, while Chairman and CEO Timothy Knavish and retiring CFO Vincent Morales received none. At the 2026 Annual Meeting on April 16, 2026, shareholders elected all 12 director nominees (with some opposition, notably 15,994,919 votes against Catherine R. Smith), approved executive compensation, ratified PricewaterhouseCoopers LLP as auditors, and passed the 2026 Omnibus Incentive Plan, but rejected the shareholder proposal for an independent board chair. No financial performance declines were reported in the filing.

• ·MSUs vest on May 8, 2029, based on absolute stock price appreciation from 30-day average closing price preceding May 8, 2026; requires Adjusted Earnings Per Diluted Share threshold for FY ending December 31, 2028.
• ·Highest director opposition: Catherine R. Smith (15,994,919 against votes).
• ·Shareholder proposal for independent board chair: 59,695,284 For vs. 126,745,338 Against.

21-04-2026

On April 17, 2026, the Boards of Directors of MGE Energy, Inc. and Madison Gas and Electric Company promoted Jared Bushek from Vice President – Chief Financial Officer and Treasurer to Executive Vice President – Chief Financial Officer and Treasurer for both companies, effective May 1, 2026. In connection with the promotion, Mr. Bushek was granted a one-time retention award of restricted stock units under the 2021 Long-Term Incentive Plan with respect to 25,000 shares of MGE Energy common stock.

• ·Retention award cliff vests on the fifth anniversary of the grant date, subject to continued employment through such date.
• ·Earlier vesting upon Mr. Bushek’s death, disability, or termination without cause or resignation for good reason within 24 months following a change in control of MGE Energy.

21-04-2026

On April 17, 2026, Cerus Corporation's board of directors adopted a new Severance Plan, entering into participation agreements with key officers including CFO Kevin D. Green, COO Vivek Jayaraman, CMO Richard Benjamin, Ph.D., and CLO Chrystal N. Jensen, superseding prior arrangements. The plan offers severance benefits upon termination without cause or good reason resignation, enhanced in change-of-control scenarios with 18-24 months base salary, 1.5-2x target bonus, COBRA premiums for 18-24 months, and full equity vesting acceleration. Outside change-of-control, executives receive 12 months salary continuation, COBRA premiums, with additional prorated bonus and vesting for Jayaraman as CEO if applicable.

• ·Severance Plan filed as Exhibit 10.1
• ·Form of participation agreement filed as Exhibit 10.2
• ·Benefits triggered within 12 months following a change of control

21-04-2026

HP Inc. held its 2026 annual stockholder meeting on April 16, 2026, where all twelve director nominees were elected with strong support (for votes ranging from 618M to 649M), Ernst & Young LLP was ratified as auditors (723M for), executive compensation was approved (603M for), and the Fifth Amended 2004 Stock Incentive Plan was approved, adding 73,600,000 shares (496M for). However, the stockholder proposal for an independent board chairman was rejected (105M for vs. 548M against). No officer departures were reported.

• ·Proxy statement filed February 25, 2026, detailing Amended 2004 Plan on pages 96-104
• ·Fiscal year ends October 31, 2026
• ·Proposal 1 director votes: Kim K.W. Rucker had lowest for votes at 618,860,860 (highest against at 35,843,716)

21-04-2026

On April 17, 2026, Aron I. Schwartz, a Class II independent director of CION Investment Corp, notified the Board that he will not stand for re-election at the 2026 Annual Meeting of Shareholders on June 25, 2026, due to other professional opportunities, with no disagreement on company operations, policies, or practices. Mr. Schwartz will continue serving on the Board and its Audit, Nominating and Corporate Governance, and Compensation Committees until the Annual Meeting. The Board approved reducing its size from eight to seven members, five independent, effective June 25, 2026.

• ·Filing submitted April 21, 2026, reporting event of April 17, 2026.
• ·Securities traded on The New York Stock Exchange.

21-04-2026

Turtle Beach Corporation (TBCH) appointed Lee Haspel and Daniela Kelley as independent directors effective April 20, 2026, with Haspel joining the Nominating and Governance Committee and Audit Committee, and Kelley to serve as Audit Committee chair after the 2026 Annual Meeting. Both directors qualify as independent under Nasdaq standards, with Kelley as an audit committee financial expert, and they will receive pro-rated standard non-employee director compensation including a $50,000 annual cash retainer, $7,500 committee retainers, and 13,880 restricted shares each under the 2023 Stock-Based Incentive Compensation Plan. The appointments fulfill commitments under the March 9, 2026 Cooperation Agreement; however, Haspel has a prior affiliation with Blue Torch Capital, LP, amid the company's exploration of potential financing with Blue Torch.

• ·Mr. Haspel was a Partner at Blue Torch Capital from 2017 through 2026, with prior roles at Fifth Street Asset Management and Halcyon Asset Management; holds B.S. from Tulane University and CFA designation.
• ·Ms. Kelley is Senior Director at UiPath, Inc., former Global Head of SOX Compliance and Director of Global Controllership; over 20 years experience, CPA, B.S. from Cornell University.
• ·Company had prior term loan with Blue Torch through August 1, 2025, and is exploring potential new financing options; Mr. Haspel retains residual interest but will not be involved in negotiations.

21-04-2026

Serina Therapeutics, Inc. filed an 8-K on April 21, 2026, under Items 5.02 and 5.03, attaching its Amended and Restated Bylaws, restated for SEC filing purposes only. The bylaws outline corporate offices, seal, and detailed procedures for stockholders' meetings, including strict requirements for nominations and proposals at annual meetings, such as 90-120 day advance notice periods. No officer departures or elections are specified in the provided content.

• ·Stockholder notice for nominations or proposals must be delivered 90-120 days prior to the first anniversary of the prior year's annual meeting.
• ·In cases of advanced or delayed meetings, notice must be 120 days prior to the meeting and not later than 90 days prior or 10 days after public announcement.

21-04-2026

On April 15, 2026, Thad Beshears, a director of Trulieve Cannabis Corp. since 2015, gave notice that he will not stand for reelection to the board at the annual shareholder meeting on June 9, 2026. His decision was not due to any disagreement with the Company's operations, policies, or practices. The filing was signed by Eric Powers, Chief Legal Officer, on April 21, 2026.

21-04-2026

SafeSpace Global Corp (SSGC) reported a rotational change in its non-independent board member from FKP Advisors LLC, with Larry Kloess III's term ending on April 15, 2026, and Ben Pope assuming the role for the second year until April 15, 2027, followed by Jim Fitzgerald until April 15, 2028. FKP Advisors LLC was appointed on April 15, 2025, for a three-year term, receiving total compensation of 400,000 shares of common stock, including an initial grant and restricted stock vesting ratably on April 15, 2026, 2027, and 2028. The firm qualifies as non-independent due to eligibility for 10% commissions on new sales and 5% on renewals it generates.

• ·Annual stock grant divided equally among the three rotational members.
• ·Exhibit 10.1: Board Member Agreement with FKP Advisors LLC dated April 15, 2025.

21-04-2026

Masco Corporation announced on April 21, 2026, that Jai Shah, Group President of Plumbing and Wellness, will conclude his service on July 3, 2026. The separation agreement dated April 16, 2026, provides Mr. Shah with a $1,206,000 cash payment, prorated 2026 cash bonus and RSU equivalent, potential prorated share award under the 2024-2026 LTIP if performance goals are met, and a cash payment for remaining unvested RSUs from a March 5, 2025 retention agreement valued at the March 6, 2027 closing price, in exchange for forfeiting those RSUs.

• ·Separation agreement executed April 16, 2026
• ·Departure effective July 3, 2026
• ·Unvested RSUs under retention agreement forfeited in exchange for cash equivalent valued at closing price on March 6, 2027

21-04-2026

Warrior Met Coal, Inc. held its 2026 Annual Meeting of Stockholders on April 20, 2026, where all six incumbent director nominees were re-elected with strong support (44.0-44.6 million votes for each, less than 1.5% against). Stockholders also approved the 2026 Equity Incentive Plan (43,771,418 votes for), an advisory vote on executive compensation (43,732,168 votes for), and ratification of Ernst & Young LLP as auditors for the year ending December 31, 2026 (47,633,209 votes for), with all proposals passing overwhelmingly and no significant opposition.

• ·2026 Equity Plan adopted by Board on February 10, 2026; detailed in Proxy Statement filed March 10, 2026.
• ·Annual Meeting proposals incorporated by reference to Exhibit 10.1 (2026 Equity Plan).

21-04-2026

On April 20, 2026, Robert Half Inc. entered into amended and restated severance agreements with its five Named Executive Officers: M. Keith Waddell, Michael C. Buckley, Paul F. Gentzkow, Joseph A. Tarantino, and Harold M. Messmer. The amendments eliminate existing provisions that provided severance benefits upon voluntary termination following a change in control, to align with current best practices and market norms. Except for this change, the material terms of the agreements remain unchanged.

• ·Exhibit 10.1: Form of Amended and Restated Severance Agreement dated April 20, 2026
• ·Filing signed on behalf of Robert Half Inc. by Evelyn Crane-Oliver

21-04-2026

On April 16, 2026, Airgain, Inc. terminated the employment of its Chief Technology Officer, Ali Sadri, Ph.D., effective April 17, 2026, and eliminated the Office of the CTO while reassigning resources to the product development team to support accelerated commercialization of growth platforms. Dr. Sadri is eligible for severance benefits, including a $325,000 lump sum cash payment representing 12 months of base salary and a $57,164 prorated target bonus for 2026, subject to signing a separation agreement with a release of claims. The full separation agreement will be filed as an exhibit to the Company's Form 10-Q for the quarter ending June 30, 2026.

• ·Severance also includes continued health coverage under COBRA at the Company's expense for 12 months and vesting of all outstanding equity awards that would have vested during the 12 months following termination.

21-04-2026

Adobe Inc. announced a new $25 billion stock repurchase program authorized by its board of directors, effective through April 30, 2030, aimed at returning value to stockholders, minimizing dilution, and reducing share count. Dan Durn, EVP and CFO, expressed confidence in the company's robust cash flow and long-term value. Adobe will host an Investor Session at Adobe Summit 2026 on April 21, 2026, at 2:00 p.m. PT in Las Vegas, streamed live on its investor relations website.

• ·Repurchases may occur in the open market or through structured agreements with third parties.
• ·Event recording and materials to be available post-session on Adobe's investor relations website.